These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 3838480

  • 1. The effects of 6-mercaptopurine nucleotide derivatives on the growth and survival of 6-mercaptopurine-sensitive and -resistant cell culture lines.
    Johnston HP, Hawley P, White SE, Gibson I, Tidd DM.
    Br J Cancer; 1985 Apr; 51(4):505-14. PubMed ID: 3838480
    [Abstract] [Full Text] [Related]

  • 2. Effects of bis(6-mercaptopurine-9-beta-D-ribofuranoside)-5',5"-phosphate and its butyryl derivative on mouse leukaemia L1210 and a 6-mercaptopurine-resistant subline in culture.
    Tidd DM, Johnston HP, Gibson I.
    Biochem Pharmacol; 1982 Sep 15; 31(18):2903-12. PubMed ID: 6897189
    [No Abstract] [Full Text] [Related]

  • 3. Partial circumvention of resistance to 6-mercaptopurine by acylated P1,P2-bis(6-mercaptopurine-9-beta-D-ribofuranoside-5') pyrophosphate derivatives.
    Tidd DM, Gibson I, Dean PD.
    Cancer Res; 1982 Sep 15; 42(9):3769-75. PubMed ID: 6896675
    [No Abstract] [Full Text] [Related]

  • 4. Collateral sensitivity of 6-mercaptopurine-resistant sublines of P388 and L1210 leukemia to the new purine antagonists, 5-carbamoyl-1H-imidazol-4-yl piperonylate and 4-carbamoylimidazolium 5-olate.
    Inaba M, Fukui M, Yoshida N, Tsukagoshi S, Sakurai Y.
    Cancer Res; 1982 Mar 15; 42(3):1103-6. PubMed ID: 6277474
    [Abstract] [Full Text] [Related]

  • 5. Comparative kinetics of poly(6-thioinosinic acid) and 6-mercaptopurine treated L1210 cells.
    Tomasovic SP, Higashikubo R, Cohen AM, Broom AD.
    Cytometry; 1982 Jul 15; 3(1):48-54. PubMed ID: 6889485
    [Abstract] [Full Text] [Related]

  • 6. N-benzyladriamycin-14-valerate versus progressively doxorubicin-resistant murine tumours: cellular pharmacology and characterisation of cross-resistance in vitro and in vivo.
    Ganapathi R, Grabowski D, Sweatman TW, Seshadri R, Israel M.
    Br J Cancer; 1989 Dec 15; 60(6):819-26. PubMed ID: 2605093
    [Abstract] [Full Text] [Related]

  • 7. Some biochemical characteristics of L1210 cell lines resistant to 6-mercaptopurine and 6-thioguanine and with increased sensitivity to methotrexate.
    Strobel-Stevens JD, El Dareer SM, Trader MW, Hill DL.
    Biochem Pharmacol; 1982 Oct 01; 31(19):3133-7. PubMed ID: 6890814
    [Abstract] [Full Text] [Related]

  • 8. Basis of observed resistance of L1210 leukemia in mice: methotrexate, 6-thioguanine, 6-methylmercaptopurine riboside, 6-mercaptopurine, 5-fluorouracil, and 1-beta-D-arabinofuranosylcytosine administered in different combinations.
    Kim K, Blechman WJ, Riddle VG, Pardee AB.
    Cancer Res; 1981 Nov 01; 41(11 Pt 1):4529-34. PubMed ID: 7198006
    [Abstract] [Full Text] [Related]

  • 9. Metabolism and mechanisms of action of 9-(tetrahydro-2-furyl)-6-mercaptopurine in Chinese hamster ovary cells.
    Drake S, Burns RL, Nelson JA.
    Chem Biol Interact; 1982 Jul 15; 41(1):105-15. PubMed ID: 6807556
    [Abstract] [Full Text] [Related]

  • 10. Effects of the L isomer (+)-1,2-bis(3,5-dioxopiperazine-1-yl)propane on cell survival and cell cycle progression of cultured mammalian cells.
    Traganos F, Darzynkiewicz Z, Melamed MR.
    Cancer Res; 1981 Nov 15; 41(11 Pt 1):4566-76. PubMed ID: 6171341
    [Abstract] [Full Text] [Related]

  • 11. Uptake, initial effects, and chemotherapeutic efficacy of harringtonine in murine leukemic cells sensitive and resistant to vincristine and other chemotherapeutic agents.
    Chou TC, Schmid FA, Feinberg A, Philips FS, Han J.
    Cancer Res; 1983 Jul 15; 43(7):3074-9. PubMed ID: 6189591
    [Abstract] [Full Text] [Related]

  • 12. Kinetics of reduction in viability of cultured leukemia L1210 cells exposed to purine analogs.
    Wilkoff LJ, Dulmadge EA, Lloyd HH.
    Chemotherapy; 1977 Jul 15; 23(3):179-91. PubMed ID: 402255
    [Abstract] [Full Text] [Related]

  • 13. Differential effect of the calmodulin inhibitor trifluoperazine in modulating cellular accumulation, retention and cytotoxicity of doxorubicin in progressively doxorubicin-resistant L1210 mouse leukemia cells. Lack of correlation between cellular doxorubicin levels and expression of resistance.
    Ganapathi R, Grabowski D.
    Biochem Pharmacol; 1988 Jan 15; 37(2):185-93. PubMed ID: 3342075
    [Abstract] [Full Text] [Related]

  • 14. Action of dihydroxyanthraquinone on cell cycle progression and survival of a variety of cultured mammalian cells.
    Traganos F, Evenson DP, Staiano-Coico L, Darzynkiewicz Z, Melamed MR.
    Cancer Res; 1980 Mar 15; 40(3):671-81. PubMed ID: 6162553
    [Abstract] [Full Text] [Related]

  • 15. PTT.119, p-F-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met ethoxy HCl, a new chemotherapeutic agent active against drug-resistant tumor cell lines.
    Yagi MJ, Chin SE, Scanlon KJ, Holland JF, Bekesi JG.
    Biochem Pharmacol; 1985 Jul 01; 34(13):2347-54. PubMed ID: 4040366
    [Abstract] [Full Text] [Related]

  • 16. Proliferation-dependent topoisomerase II content as a determinant of antineoplastic drug action in human, mouse, and Chinese hamster ovary cells.
    Sullivan DM, Latham MD, Ross WE.
    Cancer Res; 1987 Aug 01; 47(15):3973-9. PubMed ID: 3038304
    [Abstract] [Full Text] [Related]

  • 17. 6-Mercaptopurine-induced potentiation of active immunotherapy in L1210-bearing mice treated with concanavalin A-bound leukemia cell vaccine.
    Kataoka T, Akahori Y, Sakurai Y.
    Cancer Res; 1984 Feb 01; 44(2):519-24. PubMed ID: 6537896
    [Abstract] [Full Text] [Related]

  • 18. Additional nucleotide derivatives of mitosenes. Synthesis and activity against parental and multidrug resistant L1210 leukemia.
    Iyengar BS, Dorr RT, Remers WA.
    J Med Chem; 1991 Jul 01; 34(7):1947-51. PubMed ID: 1906107
    [Abstract] [Full Text] [Related]

  • 19. Selection and characterisation of murine leukaemia L1210 cells with high-level resistance to the cytostatic activity of the acyclic nucleoside phosphonate 9-(2-phosphonylmethoxyethyl) adenine (PMEA).
    Balzarini J, Hatse S, Naesens L, De Clercq E.
    Biochim Biophys Acta; 1998 Mar 12; 1402(1):29-38. PubMed ID: 9551083
    [Abstract] [Full Text] [Related]

  • 20. Resistance to purine and pyrimidine nucleoside and nucleobase analogs by the human MDR1 transfected murine leukemia cell line L1210/VMDRC.06.
    Zeng H, Lin ZP, Sartorelli AC.
    Biochem Pharmacol; 2004 Sep 01; 68(5):911-21. PubMed ID: 15294454
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.